Private Advisor Group, LLC Scynexis Inc Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$4.94 - $7.69 $98,800 - $153,800
-20,000 Reduced 50.0%
20,000 $122,000
Q3 2021

Oct 14, 2021
BUY
$5.3 - $7.89 $106,000 - $157,800
20,000 Added 100.0%
40,000 $212,000
Q4 2020

Apr 01, 2021
BUY
$4.28 - $7.87 $85,600 - $157,400
20,000 New
20,000 $153,000

Others Institutions Holding SCYX

# of Institutions
48
Shares Held
13.7M
Call Options Held
21.9K
Put Options Held
2.6K
View Full List

About SCYNEXIS INC

SCYX Quotes by TradingView
  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email